The Need for Change: Evaluating the Medical Necessity of Gender Reassignment Through International Standards by Ayers, Chad
Washington and Lee Journal of Civil Rights and Social Justice
Volume 18 | Issue 2 Article 9
3-1-2012
The Need for Change: Evaluating the Medical
Necessity of Gender Reassignment Through
International Standards
Chad Ayers
Follow this and additional works at: https://scholarlycommons.law.wlu.edu/crsj
Part of the Civil Rights and Discrimination Commons, Health Law and Policy Commons,
Human Rights Law Commons, and the Sexuality and the Law Commons
This Note is brought to you for free and open access by the Washington and Lee Journal of Civil Rights and Social Justice at Washington & Lee
University School of Law Scholarly Commons. It has been accepted for inclusion in Washington and Lee Journal of Civil Rights and Social Justice by an
authorized editor of Washington & Lee University School of Law Scholarly Commons. For more information, please contact lawref@wlu.edu.
Recommended Citation
Chad Ayers, The Need for Change: Evaluating the Medical Necessity of Gender Reassignment Through International Standards, 18 Wash. &




The Need for Change:  Evaluating the 
Medical Necessity of Gender Reassignment 
Through International Standards 
Chad Ayers* 
Table of Contents 
 Introduction .................................................................................. 352 
 I. Overview of Transgender Medical Needs .................................... 354 
 II. Barriers to Transition-Related Medical Care in the United States359 
  A. State Medicaid Statutes ......................................................... 360 
  B. Private Insurance Companies ................................................ 363 
  C. Consequences of the Difficulty to Access Transition- 
   Related Care .......................................................................... 365 
 III. The International Organizational Approach to  
  Transgender Healthcare ................................................................ 367 
  A. Addressing Discrimination in Healthcare: 
   the Yogyakarta Principles ..................................................... 367 
  B. Addressing Specific Needs of Transgender Individuals: 
   The World Professional Association for Transgender Health369 
 IV. The European Approach to Transition-Related Medical Care ..... 371 
  A. The Changing Legal Landscape ............................................ 373 
  B. Coverage of Transition-Related Procedures in 
   Specific Countries ................................................................. 376 
   1. The United Kingdom ...................................................... 376 
   2. Germany and Sweden ..................................................... 379 
   3. Italy and Spain ................................................................ 382 
   4. Summary of the Country-by-Country Analysis .............. 384 
 V. Conclusion:  Applying Lessons from the International 
  Community to the United States .................................................. 385 
 
                                                                                                                 
 * Candidate for J.D., Washington and Lee University School of Law, May 2012; 
B.A., University of Virginia, May 2009.  I would like to thank my faculty advisor, Professor 
Ann Massie, my Note editor, Kate Lester, and the Editorial Board of the Washington and 
Lee Journal of Civil Rights and Social Justice for all of their support during the Note writing 
process. 
352 18 WASH. & LEE J.C.R. & SOC. JUST. 351 (2012) 
“Surgery is not what transsexualism is ultimately about.  Transsexualism is 
about life.” 
- Jamison Green1 
Introduction 
In his book, Becoming a Visible Man, Jamison Green discusses his 
experience of being born a biological female.2  While Green’s parents 
taught him the expected societal conduct of a little girl, such as cleaning 
and housework, he felt more comfortable wearing his father’s sergeant cap 
from World War II and climbing trees.3  Green describes 1991 as his year 
of initiation into manhood.4  During that year, he completed sex 
reassignment surgery (SRS), was reissued his corrected birth certificate, 
and was “accept[ed] into a community of men.”5  The decision to undertake 
the full series of surgeries for SRS is not for everyone, but Green had a 
strong desire to live in the body he felt he was meant to have from the start 
of his life.6  He therefore undertook the procedures at a staggering cost.7  
During the first year, he spent three weeks on disability and paid $10,038.8  
The subsequent two years would cost him an additional $33,025 and ten 
weeks on disability.9  The total cost was $43,063 with a projected ongoing 
cost of $2,700 per year for continued hormone treatment.10 
Many transgender individuals are not as fortunate as Green and cannot 
afford the high costs associated with hormone therapy and surgeries.  Some 
individuals have taken extreme measures to obtain money and hormones, as 
evidenced by a 2007 ABC News story about transgender prostitutes.11  The 
                                                                                                                 
 1. JAMISON GREEN, BECOMING A VISIBLE MAN 89 (2004). 
 2. See id. at 11 (explaining his struggle against the societal norms of a female child). 
 3. See id. (providing anecdotes of his childhood struggles but emphasizing that his 
family encouraged his intellectual development and physical freedom). 
 4. Id. at 28. 
 5. See id. (elaborating upon his initiation into new communities by stating that he 
took on responsibilities in the newly emerging transgender community). 
 6. See id. at 99 (explaining his strong desire for permanent transition-related surgery 
in the summer of 1988). 
 7. See id. at 116–18 (outlining the costs of all of the procedures undertaken). 
 8. Id. at 117. 
 9. Id. at 117–18. 
 10. Id. 
 11. See Russell Goldman, Making Change:  The Cost of Being Transgender, ABC 
NEWS, May 10, 2007, http://abcnews.go.com/Health/story?id=3156598&page=1 (last visited 
Nov. 1, 2011) (providing accounts of transgender prostitutes) (on file with the Washington 
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report told of young girls, including twenty-two-year-old Kenyatta, who 
engaged in prostitution a few times per month in order to obtain money to 
purchase illegal hormones on the black market.12  Although cheaper than 
hormones obtained through a physician, illegal hormones carry a higher 
risk for complications.13  Without the supervision of a physician, Kenyatta 
has an increased chance of developing deadly blood clots in her lungs, legs, 
heart, and brain.14 
Some transgender individuals take part in medical tourism and travel 
to other countries.15  One example is Monika Weiss, who went to Thailand 
in order to undergo procedures to become a woman.16  She spent one-third 
of the amount of money she would have had to pay in the United States.17  
One need spend only a few minutes searching the Internet to find the 
numerous websites advertising Thailand’s cheap and easily accessible 
gender reassignment procedures.18  There are consequences for traveling 
abroad to receive surgery.  Many surgeries are advertised on websites,19 
requiring individuals to rely on their own knowledge while shopping for 
surgeons.  A person must, therefore, be extremely knowledgeable in order 
                                                                                                                 
and Lee Journal of Civil Rights and Social Justice). 
 12. See id. (discussing the ease of access to hormones on the black market). 
 13.  See id. (discussing the increased health risks of taking illegal hormones without 
supervision from a physician). 
 14. See id. (stating that progesterone has been linked to breast cancer and estrogen use 
can lead to blood clots). 
 15. See Richard S. Ehrlich, Everything You Always Wanted to Know About 
Sex . . . Changes, CNN, Feb. 24, 2010, http://www.cnngo.com/bangkok/play/everything-
youve-ever-wanted-know-about-sex-changes-379486 (last visited Nov. 1, 2011) (discussing 
the price of surgery in the United States and American people traveling to Thailand for 
cheaper prices) (on file with the Washington and Lee Journal of Civil Rights and Social 
Justice). 
 16. See id. (describing the personal decision of one transgender individual to travel to 
Thailand). 
 17. See id. (“‘I paid one-third of what I would have paid in America for the same 
procedures,’ [Monika] says while recovering in Bangkok.”). 
 18. See Aesthetic Plastic Surgery & Sex Change Surgery Ctr., BANGKOK PLASTIC 
SURGERY, http://www.bangkokplasticsurgery.com (last visited Nov. 1, 2011) (providing a 
wide range of services including:  breast augmentation surgery, sex change surgery, and 
facial feminization surgery) (on file with the Washington and Lee Journal of Civil Rights 
and Social Justice); see also DOCTOR SARAN, http://doctorsaran.com/ (last visited Nov. 1, 
2011) (providing a package price list for SRS) (on file with the Washington and Lee Journal 
of Civil Rights and Social Justice). 
 19. See, e.g., Aesthetic Plastic Surgery & Sex Change Surgery Ctr., supra note 18 
(informing readers about surgeries); see also DOCTOR SARAN, supra note 18 (describing the 
various surgeries offered and providing prices). 
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to ensure adequate medical care abroad.  Even if a patient obtains 
successful surgery, the recovery period could still pose a problem.  For 
example, if a patient does not want to pay additional money, he or she must 
return home for later portions of the recovery period, which means he or 
she will not be under the supervision of the doctor who performed the 
surgery.20 
Monika and Kenyatta’s stories illuminate a serious issue in the United 
States:  If individuals need medical treatment in order to live in what they 
feel is their correct biological body, why are United States citizens turning 
to prostitution, the black market, and cheap procedures in foreign countries?  
This Note will answer this question and advance a solution by examining 
international and European standards.  Part I will provide an overview of 
transgender medical needs in the United States.  Part II will discuss the 
current barriers in the United States.  Part III will examine standards created 
by international organizations in order to develop medical standards for the 
United States.  Part IV will study how European countries implement those 
international standards.  Finally, Part V will apply the lessons from 
international standards and European examples to the situation in the 
United States in order to remedy the pressing problems affecting 
transsexuals. 
I.  Overview of Transgender Medical Needs 
Understanding the current state of healthcare for transitioning 
individuals requires knowledge of the terminology regarding transgender 
people as well as how the medical community approaches the situation.  
The term “transgender” is now used as “an umbrella term for anyone whose 
gender identity is at odds with his [or her] birth gender.”21  “Transsexual” is 
a specific classification under the broader term of “transgender” and is used 
to describe individuals who have an “internal gender identity that does not 
                                                                                                                 
 20. See SRS (Penile Skin Inversion), PREECHA AESTHETIC INST., http://pai.co.th/srs-
penile-skin-inversion/ (last visited Nov. 1, 2011) (detailing an example of a post-operative 
recovery period) (on file with the Washington and Lee Journal of Civil Rights and Social 
Justice).  The institute requires that the patient stay in Thailand an additional fifteen days 
after surgery.  Id.  The recovery period, however, can last 4–8 weeks, during which 
strenuous activity is discouraged.  Id.  If complications arise after the initial fifteen days, the 
patient will often be in a different country than his or her original physician. 
 21. JOHN M. BURDA, GAY, LESBIAN, AND TRANSGENDER CLIENTS:  A LAWYER’S GUIDE 
156 (2008) (detailing a basic overview of transgender issues). 
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match the sex assigned at birth.”22  Transsexuals often undergo hormone 
therapy or SRS in order to correct their biological sex.23  In order for 
transsexuals to pursue medical treatment in the United States, they usually 
must be diagnosed with some type of gender identity disorder.24 
Gender Identity Disorder (GID) is defined in the American Psychiatric 
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV),25 
which lists five necessary criteria: 
1. Evidence of a strong and persistent cross-gender 
identification; 
2. Cross-gender identification must be more than a mere desire 
for the perceived cultural advantages of the other sex; 
3. Evidence must exist of either a persistent discomfort with or a 
sense of inappropriateness in the gender role of one’s assigned 
sex; 
4. The person must not have a concurrent physical intersex 
condition; and 
5. Evidence must exist of clinically significant distress or 
impairment in social, occupational, or other important areas of 
functioning. 26 
Many individuals diagnosed with GID often feel intense distress called 
gender dysphoria.27  If untreated, gender dysphoria can lead to severe 
depression and even suicide in serious cases.28  To treat these symptoms, 
transgender healthcare experts recommend a triadic therapy, which includes 
a real-life experience in the desired gender role, hormone therapy, and 
SRS.29 
                                                                                                                 
 22. See id. at 156 (distinguishing transsexuals from cross-dressers because cross-
dressers, while dressing as the opposite sex, maintain an identity as a man or a woman and 
thus conform to societal expectations). 
 23. See id. (stating that transsexuals often feel persistent distress, which is relieved by 
hormone therapy and SRS). 
 24. See GREEN, supra note 1, at 93 (discussing the negative effects of classifying all 
transsexuals as having a mental disorder). 
 25. See AM. PSYCHIATRIC ASSOC., DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL 
DISORDERS 576–82 (4th ed. 2000) [hereinafter DSM-IV] (providing standard criteria for the 
classification of mental disorders). 
 26. Id. at 581–82. 
 27. See BURDA, supra note 21, at 156 (“Gender dysphoria refers to the persistent 
distress that transsexuals feel toward the gender assigned to them at birth.”). 
 28. See id. at 157 (“Untreated, the condition causes severe depression and, in some 
profound cases, leads to suicide.”). 
 29. See id. at 156 (outlining the usual prescribed treatment for gender dysphoria). 
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The real-life experience is an extended period of time during which a 
patient must live in his or her preferred gender role.30  Physicians use the 
real-life experience, often for a twelve-month minimum, to test whether 
there is further consolidation of gender identity in the patient.31  Coupled 
with the real-life experience, psychotherapy helps to further the goal of a 
stable lifestyle.32  Therapy helps to illuminate the patient’s history as well 
as his or her current expectations.33  The goal of these two procedures is to 
ensure that the patient actually wants to undergo gender reassignment and 
that he or she is psychologically prepared for the start of the process.34 
Once a patient has begun the real-life experience and completed three 
months of psychotherapy, a physician may prescribe hormone treatment.35  
The positive effects of hormones often take years to develop; hormones are 
administered over a period of time before, during, and after SRS.36  
Numerous medical risks are associated with hormone therapy, including 
adverse effects on liver function and an increased risk of 
hyperprolactemia.37  As a result of these risks, there is a strong need for 
                                                                                                                 
 30.  See RACHEL ANN HEATH, THE PRAEGER HANDBOOK OF TRANSSEXUALITY:  
CHANGING GENDER TO MATCH MINDSET 80 (Judy Kuriansky ed., 2006) (stating that the real-
life experience is often for a minimum of twelve months but can be extended up to two 
years). 
 31. See WORLD PROF. ASSOC. OF TRANSGENDER HEALTH [WPATH], STANDARDS OF 
CARE FOR GENDER IDENTITY DISORDERS 14 (2001), available at 
http://www.wpath.org/documents2/socv6.pdf (outlining the three readiness criteria for 
hormone therapy). 
 32. See id. at 12 (explaining that the goal of psychotherapy is not to cure GID but to 
help provide a stable lifestyle with realistic chances for relationships, work, and gender 
identity expression). 
 33. See id. (“[Therapy] enable[s] the patient’s history [to] be appreciated, current 
dilemmas to be understood, and unrealistic ideas and maladaptive behaviors to be 
identified.”). 
 34. See id. (defining the process of psychotherapy).  The author notes: 
The therapist should make clear that it is the patient’s right to choose among 
many options.  The patient can experiment over time with alternative 
approaches.  Ideally, psychotherapy is a collaborative effort.  The therapist must 
be certain that the patient understands the concepts of eligibility and readiness, 
because the therapist and patient must cooperate in defining the patient’s 
problems, and in assessing progress in dealing with them. 
Id. 
 35. See HEATH, supra note 30, at 113 (stating that transsexed men begin taking 
testosterone and transsexed women begin taking estrogen once a diagnosis of transsexualism 
is made). 
 36. See id. (stating that the positive effects of hormone therapy takes two or more 
years to develop). 
 37. See id. at 116–17 (concluding that hormone therapy is reasonably safe for both 
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close observation by a physician or endocrinologist throughout the entire 
period of hormone therapy.38 
The final part of the suggested triadic therapy is the surgery itself, 
which many patients do not choose.39  SRS may include a number of 
different procedures.  Genital reconstruction surgery is complex for both 
sexes.40  For transsexual women, one procedure is called a vaginoplasty, 
which involves the creation of a vagina using both penile skin and a 
urethral flap.41  For transsexual men, phalloplasty, or the creation of a penis, 
is accomplished through a variety of intricate methods.42  Men can 
additionally receive a hysterectomy, oophorectomy, vaginectomy, and 
mastectomy.43  After the primary surgical procedures, transsexual 
                                                                                                                 
transsexed women and men, but that the risks associated with it require observation by an 
endocrinologist).  Hyperprolactemia is a disorder of the pituitary gland that results in an 
excess secretion of prolactin.  Id. at 116. 
 38. See id. at 116 (stating that an endocrinologist should be aware of the possible 
complications associated with hormone therapy and make the risks clear to the patient). 
 39. See id. at 82 (explaining Harry Benjamin’s categories of transvestites and 
transsexuals).  A nonsurgical transsexual frequently dresses as the opposite biological sex 
and requests hormone therapy to maintain a satisfactory quality of life.  Id.  What Benjamin 
terms as a “true transsexual” requests gender reassignment surgery and hormone therapy.  
Id. 
 40. See id. at 124 (“The surgical procedures required to transform the male genitals 
into their female equivalent are complex.”).  Even though complex, genital reconstruction 
surgery “for transsexed women provides a satisfying outcome both cosmetically and 
functionally in most cases.”  Id. at 134.  The procedures for transsexed men, however, 
“involve an unreasonable degree of cost, risk, and compromise.”  Id.  Much of the 
complication results from the goal of phalloplasty, which is to “create a penis that has erotic 
sensation and is capable of both sexual intercourse and urination while standing.”  Id.  Since 
the procedures for transsexed men are so complex and uncertain, many men are content with 
hormone therapy and cosmetic surgeries.  Id. 
 41. See id. at 124–29 (describing the surgical procedure of a vaginoplasty in detail). 
 42. See id. at 134–37 (detailing the different options for the phalloplasty surgery).  
One method for phalloplasty “uses a bony skin graft from the underside of the forearm.”  Id. 
at 134.  Another method produces a tube from “innervated skin from the lower abdomen.”  
Id. at 135.  The urethra is then constructed using a fold of skin from the labia majora and 
placed within the penis to allow urination while standing.  Id.  As an alternative to 
phalloplasty, men can undergo metoidioplasty, which creates a penis by using the enlarged 
clitoris that results from prolonged testosterone use.  Id. at 136. 
 43. See id. (discussing a new surgical procedure that uses a one-stage procedure).  The 
study notes: 
Mastectomy and chest contouring are performed at the same time as 
oophorectomy (removal of the ovaries) and hysterectomy.  The procedure 
concludes with phalloplasty, the penis being formed from a skin flap obtained 
from the anterior abdomen wall. 
Id. 
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individuals can also receive treatment in the form of speech therapy, voice 
box surgery, and facial feminization therapy.44 
The costs and extent of psychological evaluations, hormone therapy, 
and surgical procedures make them difficult to obtain for a large portion of 
the transgender community.45  A 2001 survey found that the average cost 
for male to female SRS was approximately $10,400.46  Prices of well-
known surgeons ranged from $4,500 to $26,000 for male to female 
surgeries.47  Female to male surgeries ranged from $4,000 up to $60,000 
and averaged $18,000 in 2001.48  In addition to surgeries, the study 
estimated mental therapy sessions at a rate of $125 per hour and assumed 
the average person to need at least four sessions annually.49  Patients who 
have already transitioned and are functioning well in their new gender roles 
will need approximately two or three sessions per year, whereas a newly 
transitioned or transitioning individual may need up to twenty sessions per 
year.50 
Hormones are also costly.51  Male to female patients could spend well 
over $1,000 for the first year of hormone treatment and over $2,000 for the 
second year.52  After transitioning, the price for hormones remains fairly 
                                                                                                                 
 44. See id. at 141–54 (discussing the various ancillary procedures available to 
transsexual patients). 
 45. See BURDA, supra note 21, at 157 (stating that SRS is expensive and often not 
covered by many Medicaid statutes and private insurance companies, resulting in many 
transsexuals not being able to afford the procedures). 
 46. See MARY ANN HORTON, THE COST OF TRANSGENDER HEALTH BENEFITS, OUT & 
EQUAL WORKPLACE SUMMIT 1 (2008), http://www.tgender.net/taw/thb/THBCost-
OE2008.pdf (last visited Oct. 18, 2011) (estimating the cost of Transgender Health Benefits 
for United States residents) (on file with the Washington and Lee Journal of Civil Rights and 
Social Justice).  The study notes: 
The author sent a survey in 2002 to all surgeons and clinics who were members 
of HBIGDA (Harry Benjamin International Gender Dysphoria Association), 
asking for data of primary surgeries performed in 2001:  number, cost, and 
fraction who were US residents, separately for MTF (male to female) and FTM 
(female to male) patients. 
Id. at 2. 
 47. Id. 
 48. Id. at 1–2. 
 49. See id. (estimating that a total first year cost of mental health therapy would total 
$750). 
 50. Id. at 5–6. 
 51. See id. at 6–7 (discussing the costs associated with hormone therapy). 
 52. See id. at 6 (detailing the typical path of hormone treatment and the total cost of 
medicines per year). The study notes: 
In the first year, the Premarin dose gradually increases from .625 mg/day to 
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consistent at approximately $400 per year.53  Female to male patients have a 
simpler regimen that costs approximately $229 per year.54  Transitioning 
individuals face additional charges for doctor’s visits and yearly blood tests 
to determine hormone levels.55 
II.  Barriers to Transition-Related Medical Care in the United States 
Transsexuals seeking medical treatment in the United States face 
difficulties inherent in the transgender experience as well as difficulties 
resulting from the lack of uniform medical standards among the states.56  
For example, an October 2010 survey evaluating transgender discrimination 
in health care found that study participants were less likely than the general 
population to have health insurance and more likely to be covered by state 
programs such as Medicaid.57  Medicaid statutes among the states differ as 
to whether or to what extent SRS and related services qualify as “medically 
necessary.”58  Private insurance companies also pose problems for 
transgender individuals because most of them either expressly exclude 
                                                                                                                 
3.75 mg/day, the dosage of Spironolactone remains steady at 100 mg/day, for a 
total cost of $1,088.  In the second year, .5 mg/day of Premarin, 100 mg/day of 
Spironolactone, and 200 mg/day of Prometrium is assumed, costing a total of 
$2,376. 
Id. 
 53. See id. (“In years 3 and on, a maintenance dose of 1.25 mg of Premarin, costing 
$382 per year is assumed.”). 
 54. See id. (assuming that it is a constant dosage of 1.0 cc of injectable Depo-
Testosterone every two weeks that does not change over the lifetime of the patient). 
 55. See id. at 7–8 (stating that costs for doctor’s visits will typically be $510 in the 
first year, $385 the second year, and $225 in subsequent years). 
 56. See HEATH, supra note 30, at 169 (stating that transsexuals often “experience 
prejudice and . . . negative responses from caregivers”). 
 57. See JAIME M. GRANT ET AL., THE NAT’L CTR. FOR TRANSGENDER EQUAL. & THE 
NAT’L GAY AND LESBIAN TASK FORCE, NAT’L TRANSGENDER DISCRIMINATION SURVEY 
REPORT ON HEALTH AND HEALTH CARE 8 (2010), available at http://transequality. 
org/PDFs/NTDSReportonHealth_final.pdf [hereinafter NCTE] (stating that 19% of the 
survey sample lacked any health insurance compared to 15% of the general population). 
 58. See Know Your Rights—Transgender People and the Law, AM. CIVIL LIBERTIES 
UNION (ACLU), Nov. 19, 2009, http://www.aclu.org/hiv-aids_lgbt-rights/know-your-rights-
transgender-people-and-law (last visited Oct. 18, 2011) (stating that it is difficult to get 
Medicaid coverage of transition-related care) (on file with the Washington and Lee Journal 
of Civil Rights and Social Justice).  The article further states that “[n]o state explicitly 
permits it, and many states explicitly deny it.  In those that do not explicitly permit or deny 
it, coverage may still be denied under the rationale that transition-related treatment is 
‘experimental’ or ‘cosmetic.’”  Id. 
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transition-related services or are unclear about the services covered.59  A 
lack of federal legislation providing for uniform medical standards among 
the states contributes to the difficulty of funding coverage for transition-
related care.60 
A.  State Medicaid Statutes 
Medicaid statutes vary from state to state.61  The federal Medicaid 
statute does not exclude reimbursement of treatments related to SRS, but 
states can choose whether to reimburse certain medical procedures under 
their programs.62  There are some favorable regulations and case law 
maintaining that states cannot categorically deny compensation for SRS 
under Medicaid programs, but there is also case law upholding states’ 
denial of reimbursement for treatment related to SRS.63 
Although states may choose which medical procedures to reimburse 
under Medicaid, regulations constrain that choice.64  For example, states 
may not deny services to an otherwise eligible individual solely because of 
diagnosis, type of illness, or condition.65  The United States Court of 
Appeals for the Eighth Circuit has held that states cannot absolutely 
exclude the only known available medical treatment for a gender identity 
disorder because that would be considered an arbitrary denial of benefits 
based solely on the diagnosis, type of illness, or condition.66  In Pinneke v. 
                                                                                                                 
 59. See id. (stating that coverage of transition-related surgery or treatment depends on 
the specific contract with the health insurance companies). 
 60. See id. (stating that the two government programs addressing transition-related 
care, Medicare and the Civilian Health and Medical Program of the Uniformed Services, 
exclude transition-related services). 
 61. See BURDA, supra note 21, at 174 (providing some examples of states that 
excluded SRS). 
 62. See id. (stating that there is some favorable case law, but that it is difficult to 
obtain reimbursement through Medicaid). 
 63. See discussion infra at notes 64–83 (discussing case law allowing states to deny 
reimbursement for transition-related services). 
 64. See 42 U.S.C. § 1396(a)(A)(10) (2010) (providing a list of care and services that 
must be provided in order for medical assistance).  
 65. See 42 C.F.R. § 440.230(c) (2011) (“The Medicaid agency may not arbitrarily 
deny or reduce the amount, duration, or scope of a required service under §§ 440.210 and 
440.220 to an otherwise eligible recipient solely because of the diagnosis, type of illness, or 
condition.”). 
 66. See Pinneke v. Preisser, 623 F.2d 546, 549 (8th Cir. 1980) (stating that there 
cannot be an irrebuttable presumption that SRS is never medically necessary).  Appellee-
Plaintiff Pinneke underwent extensive testing and doctors concluded that she had a 
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Preisser, the court stated that the Iowa Department of Social Services could 
not create an irrebuttable presumption that SRS can never be medically 
necessary and that it must take into account the applicant’s diagnosed 
condition, the prescribed treatment, and the knowledge of the medical 
community.67  The Supreme Court of Minnesota, in Doe v. State,68 required 
an unbiased medical evaluation of whether SRS is medically necessary as 
determined on a case-by-case basis.69 
Although cases such as Pinneke and Doe illustrate that there have been 
some successes in obtaining funding for SRS, there are also numerous cases 
reaching the opposite result under a variety of rationales.  In Casillas v. 
Daines,70 Terri Casillas claimed that the New York Commissioner of 
Health deprived her of rights protected by the Constitution and federal law 
when he denied her Medicaid coverage for surgeries and services to treat 
her GID.71  The New York State Department of Health adopted a regulation 
that prohibits state Medicaid reimbursement for services related to gender 
reassignment.72  Casillas, with the support of her current psychologist and 
                                                                                                                 
transsexual personality.  Id. at 547.  Eligible under the Medicaid program, she applied for 
funding of her SRS, but was denied.  Id.  The court found that sex conversion surgery is the 
only medical treatment available to relieve the problems of a true transsexual.  Id. at 548.  
Furthermore, the court concluded that the state plan was an arbitrary denial of benefits based 
solely on the “diagnosis, type of illness, or condition” since it absolutely excluded the only 
known treatment.  Id. at 549. 
 67. See id. at 549–50 (stating that the decision of whether a certain treatment is 
“medically necessary” rests with the individual’s physician and not with government 
officials). 
 68. See Doe v. State, 257 N.W.2d 816, 821 (Minn. 1977) (finding that the Minnesota 
Welfare Department’s denial of medical assistance benefits to an adult male transsexual was 
arbitrary and unreasonable).  Jane Doe was selected to undergo sex conversion surgery at 
one of the University of Minnesota Hospitals.  Id. at 817.  The federal funding for the 
program ended before Doe could undertake surgery.  Id. 
 69. See id. at 820 (“The determination of medical necessity through a thorough 
medical evaluation of the individual applicant will ensure that those individuals genuinely 
requiring sex conversion surgery will be able to obtain it but will deny benefits to persons 
not demonstrating such medical necessity.”). 
 70. See Casillas v. Daines, 580 F. Supp. 2d 235, 247 (S.D.N.Y. 2008) (granting the 
motion of the defendant for judgment on the pleadings).  Terri Casillas claimed that the New 
York Commission of Health violated her equal protection rights by denying her 
reimbursement under Medicaid for services related to GID.  Id. at 237.  The state agency 
cited “serious complications” from the surgeries and the administration of estrogen.  Id. at 
247.  The court found that the state agency’s rationale provided a more than sufficient 
rational basis related to the government interest of protecting the health of its citizens and 
the conservation of limited medical resources.  Id. 
 71. See id. at 237 (arguing that SRS, hormone therapy, and real-life experience 
together are an effective treatment for transsexualism or profound GID). 
 72. See id. at 237 (citing 18 N.Y.C.R.R. § 505.2(1) (2011)). 
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her prior treating psychiatrist, argued that the treatments were medically 
necessary.73  Casillas argued that she had been denied equal protection on 
the basis of her diagnosis, but the court disagreed.74  The state agency cited 
serious complications from the surgery and from the administration of 
estrogen.75  The court ruled against Casillas and found that the agency’s 
explanation survived rational basis review because it was protecting the 
health of state citizens and conserving limited medical resources.76 
Other courts have upheld the categorical denial of reimbursement for 
transition-related medical care on the grounds that SRS is “experimental” 
and that there is disagreement with regards to the efficacy of such 
procedures.77  The court in Rush v. Parham78 stated that the federal 
Medicaid statute gives states broad discretion for adopting standards and 
only requires that those standards be reasonable and consistent with the 
objectives of the Act.79  In Rush, the United States Court of Appeals for the 
Fifth Circuit found that Georgia could reasonably exclude reimbursement 
of experimental treatments and remanded for the district court to determine 
if the specific procedures could be classified as such.80  In Smith v. 
Rasmussen,81 the United States Court of Appeals for the Eighth Circuit 
upheld Iowa’s prohibition on funding of SRS.82  Instead of concluding that 
                                                                                                                 
 73. See id. at 238 (“In January 2007, plaintiff was examined by a medical doctor who 
is Professor and Chairman of Plastic and Reconstructive Surgery at the Philadelphia College 
of Osteopathic Medicine who has opined that hormones, orchiectomy and vaginoplasty are 
medically necessary to treat plaintiffs with GID.”). 
 74. See id. at 246–47 (stating that the state agency satisfied a rational basis related to a 
legitimate government interest). 
 75. See id. at 247 (citing the agency’s rationale for denying reimbursement of gender 
reassignment surgeries and associated treatments). 
 76. See id. (“This provided a more than sufficient rational basis which was related to 
legitimate government interests—the health of its citizens and the conservation of limited 
medical resources.”). 
 77. See Rush v. Parham, 625 F.2d 1150, 1156 (5th Cir. 1980) (holding that Georgia 
could exclude SRS because of its status as an experimental treatment). 
 78. See id. (finding that Georgia’s definition of “medically necessary” could 
reasonably exclude experimental treatment). 
 79. See id. at 1155 (giving broad discretion to states when deciding which treatments 
to cover under Medicaid programs). 
 80. See id. at 1156–57 (remanding the case to determine if the specific procedures 
could be classified as experimental). 
 81. See Smith v. Rasmussen, 249 F.3d 755, 762 (8th Cir. 2010) (finding that the 
rulemaking process resulted in a reasonable regulation that overcame the presumption in 
favor of the treating psychiatrist). 
 82. See id. at 760–61 (describing the rulemaking process that caused the exclusion of 
SRS). 
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the procedures were categorically experimental, the court cited the 
Department of Health’s research that demonstrated differing opinions 
regarding the efficacy of SRS.83 
As evidenced by the decisions in Rush and Smith, there is 
disagreement in the United States medical community over the efficacy of 
both SRS and the various other components of transition-related care.  A 
further complication caused by the Medicaid program is that states may 
place reasonable limits on a physician’s discretion as to which medical 
procedures qualify as medically necessary.84  Even if a doctor does decide 
that transition-related care is medically necessary for a patient, a state may 
still deny coverage as long as it has a legitimate interest, such as conserving 
resources.85 
B.  Private Insurance Companies 
The difficulties associated with coverage under state Medicaid 
programs leave many transsexuals relying on private insurance in order to 
fund transition-related medical care.86  The first obstacle is affording private 
insurance.  Transgender people often find economic and educational 
opportunities inaccessible due to persistent discrimination throughout their 
lifetimes.87  Many transgender individuals drop out of school before 
finishing high school due to a lack of uniform anti-discrimination policies.88  
A large portion of the transgender community therefore faces financial 
hardships that make affording private insurance nearly impossible.89 
                                                                                                                 
 83. See id. at 761 (noting that the efficacy of surgery has been questioned). 
 84. See Rush v. Parham, 625 F.2d 1150, 1156 (5th Cir. 1980) (detailing the ability of 
states to establish standards for individual physicians in determining what services are 
appropriate). 
 85. See Smith, 249 F.3d at 761 (noting the relevance of economic concerns and the 
state’s interests in a state’s decision whether to cover SRS). 
 86. See NCTE, supra note 57, at 8 (providing the percentages of respondents’ source 
of insurance).  While 3% of respondents received insurance through Medicaid, 7% of 
respondents purchased insurance.  Id.  In addition, 51% of respondents had insurance 
through either their own employer or through someone else’s employer.  Id. 
 87. See Dean Spade, Compliance is Gendered:  Struggling for Gender Self-
Determination in a Hostile Economy, in TRANSGENDER RIGHTS 217, 218–19 (Paisley Currah, 
Richard M. Juang, & Shannon Price Minter eds., 2006) (stating that much of the economic 
and educational discrimination against transgender individuals remains legal). 
 88. See id. at 219 (stating that harassment is widespread in schools).  Many 
transgender people do not pursue higher education out of fear of applying to schools and 
needing to fill out applications, which will reveal their previous sex and name.  Id. 
 89. See id. (“Furthermore, trans people face severe discrimination in the job market 
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Even if an individual can acquire private health care, there are still the 
additional obstacles of discrimination and exclusion of procedures.  There 
has been some progress in protecting transgender individuals from 
discrimination in general.90  One example is the Patient Protection and 
Affordable Care Act which bans insurance companies from dropping or 
denying coverage because of a pre-existing condition.91  While the bill 
prevents discrimination because someone is transgender or diagnosed with 
GID, it does not prevent insurance companies from excluding certain types 
of medical procedures.92  Because contract law governs private insurance, it 
is often up to the individual to ensure that the plan he or she purchases 
includes coverage for transition-related care.93  Most insurance carriers 
either exclude many forms of transition-related care or are unclear about 
whether those services are covered.94 
Insurance companies commonly state that SRS is a cosmetic procedure 
and therefore not coverable under insurance plans.95  In Davidson v. Aetna 
Life & Casualty Co.,96  Victoria Davidson had an insurance policy through 
his employer stating that cosmetic surgeries would be covered only if the 
“surgery is necessary for the repair of non-occupational injury.”97  Aetna 
attempted to argue that sex-reassignment surgery is cosmetic and not 
necessary to repair an injury.98  The court ruled for Davidson, finding that 
                                                                                                                 
and are routinely fired for transitioning on the job or when their gender identities or 
expressions come to their supervisor’s attention.”). 
 90. See Patient Protection and Affordable Care Act, Pub. L. No. 111-148, § 1205, 124 
Stat. 119 (2010) (preventing discrimination based on one’s transgender identity);  see also 
Davidson v. Aetna Life & Cas. Ins. Co., 420 N.Y.S.2d 450, 453 (N.Y. 1979) (finding that 
SRS is not merely cosmetic surgery). 
 91. See Patient Protection and Affordable Care Act § 1205 (banning denial of 
coverage due to a previous condition); see also THE HENRY J. KAISER FAM. FOUND., 
SUMMARY OF NEW HEALTH REFORM LAW 1 (April 15, 2011), available at 
http://www.kff.org/healthreform/upload/8061.pdf (stating that the new bill extends Medicaid 
coverage to all individuals under the age of sixty-five). 
 92. See Patient Protection and Affordable Care Act §§ 1557, 2704 (prohibiting 
exclusion of preexisting conditions and preventing discrimination in coverage). 
 93. See ACLU, supra note 58 (stating that coverage depends upon the individual 
contract with the individual insurance company). 
 94. See id. (“Today, most insurance contracts either expressly exclude many forms of 
transition-related services or are unclear about whether such services are covered.”). 
 95. See Davidson, 420 N.Y.S.2d at 451 (stating that the defendant argued that the 
transsexual surgery in question was cosmetic). 
 96. See id. at 453 (finding that the SRS in question was necessary for the treatment of 
gender dysphoria). 
 97. Id. at 451. 
 98. See id. at 452–53 (stating that Aetna’s Medical Director maintained that there is 
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the procedure is performed in order to correct a psychological defect, not 
solely to improve muscle tone or physical appearance.99  While Davidson 
was a victory for transgender individuals, the case also illuminates the fact 
that the outcome is dependent upon whether courts view transition-related 
care as medically necessary.100 
C.  Consequences of the Difficulty to Access Transition-Related Care 
Because of the difficulties associated with financing SRS and related 
treatment, many transsexuals turn to negative coping mechanisms.101  In a 
2010 survey conducted by the National Center for Transgender Equality 
and the National Gay and Lesbian Task Force, surveyors asked participants 
about drug and alcohol use as a coping strategy for dealing with 
mistreatment and discrimination.102  Among respondents, 26% currently use 
or have used alcohol and drugs to cope with discrimination.103  When asked 
about suicide, 41% of respondents said they had attempted suicide.104 
Numerous individuals avoid doctors and insurance companies in the 
United States by seeking alternative sources for surgery and funding for 
surgery.105  One alternative is traveling to Thailand, which offers cheap and 
easy access to transition-related treatments.106  Hormones are particularly 
easy to find and individuals can often obtain them without a doctor’s 
                                                                                                                 
nothing physically wrong with a transsexual’s body).  He went further to say that the surgery 
was attempting to change the body to fit the transsexual’s mind.  Id. at 453. 
 99. See id. at 453 (stating that the court did not want to interfere with the professional 
judgment of medical experts).  The court characterized cosmetic surgery as “optional or 
elective.”  Id.  The medical diagnosis for the plaintiff indicated that the surgery was 
imperative in order for the plaintiff to live a normal life.  Id. 
 100. See id. at 451–53 (analyzing the current understanding of transsexualism as a 
medical diagnosis).  Ultimately, the decision to require coverage under an insurance plan 
depends on each individual’s case. 
 101. See NCTE, supra note 57, at 14 (describing the damaging coping mechanisms to 
which transsexuals turn). 
 102. See id.  (stating that the survey did not ask about general use of alcohol and drugs, 
only about use as a coping strategy). 
 103. Id.  
 104. See id. (estimating that only 1.6% of currently living Americans have attempted 
suicide). 
 105. See discussion supra Introduction (describing the personal stories of transsexuals 
who travelled to other countries for treatment). 
 106. See discussion supra Introduction (discussing the experience of Monika Weiss 
who spent one-third of what she would have in the United States). 
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prescription.107  SRS is easier to obtain due to the lack of medical standards 
associated with the Western transgender experience.108  Primarily, the 
requirement that a person live in his or her desired gender for a period of 
time, as well as the three-month psychological counseling, are not 
mandatory in Thailand.109  After surgery in another country, the patient 
faces the further problem of arranging follow-up care.110  Traveling back to 
the United States requires a patient to undergo the healing process, as well 
as continued hormone therapy, under the supervision of a doctor who did 
not perform the surgery and who does not have an extensive knowledge of 
the patient’s medical history.111  Ultimately, SRS has become a 
commercially driven enterprise.112  Patients seek out the cheapest 
procedures without considering the risks associated with those 
procedures.113 
While some transsexuals travel to other countries to obtain SRS, others 
turn to prostitution in order to afford hormones on the black market.114  One 
can obtain hormones from Mexico at a reduced price and without a doctor’s 
prescription.115  Because of the complexity of administering hormones over 
a transsexual’s lifetime, endocrinologists and physicians are crucial to 
ensuring that a person is not subject to adverse side effects.116  These side 
effects include nausea, vomiting, headaches, mood swings, blood clots, 
                                                                                                                 
 107. See Sam Winter, Country Report:  Thailand, TRANSGENDERASIA (Feb. 5, 2002), 
http://web.hku.hk/~sjwinter/TransgenderASIA/country_report_thailand.htm (last visited 
Nov. 3, 2011) (stating that local chain drug stores can carry as many as twenty-three 
hormonal preparations, which are available without a prescription) (on file with the 
Washington and Lee Journal of Civil Rights and Social Justice). 
 108. See id. (stating that the WPATH Standards of Care are not followed in Thailand). 
 109. See id. (stating that the requirements for the real life test and for psychiatric 
counseling are not needed in Thailand). 
 110. See HEATH, supra note 30, at 114 (emphasizing the need for transitioning patients 
to remain under the care of a physician). 
 111. See discussion supra Introduction (reporting the story of Monika Weiss who 
traveled to Thailand to undergo SRS). 
 112. See HORTON, supra note 46, at 2 (finding that some SRS treatments cost as much 
at $60,000). 
 113. See discussion supra Introduction (recounting stories of people who sought 
treatment in other countries due to cost). 
 114. See Goldman, supra note 11 (discussing how some New York City transsexuals 
turn to prostitution to afford treatments). 
 115. See id. (stating that hormones on the black market are usually hormones prescribed 
for menopause). 
 116. See HEATH, supra note 30, at 114 (stating that the patient should be in constant 
contact with a medical advisor throughout hormone therapy). 
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liver damage, and heart and lung complications, as well as problems with 
blood circulation and an increased chance of breast cancer.117 
There are significant consequences to a lack of uniform medical 
standards.  Transgender individuals already face significant discrimination 
and inequalities in most aspects of life, including housing, employment, and 
education.118  The high costs associated with the full transition experience 
make full treatment unobtainable for a large portion of the transgender 
community who seek to transition.119  Without an easy way to obtain 
medical care, many transsexuals face serious risks. 
III.  The International Organizational Approach to Transgender Healthcare 
Although there is division within the United States over how to 
approach transsexual medical care, the international medical community 
has begun to formulate standards of care.120  International communities, 
particularly in Europe, have seen great progress in providing protections for 
sexual orientation and gender identity, but the community has remained 
“fragmented and inconsistent.”121 
A.  Addressing Discrimination in Healthcare:  The Yogyakarta Principles 
In order to remedy these inconsistencies, human rights experts met in 
Yogyakarta, Indonesia in November 2006 and adopted the Yogyakarta 
Principles on the Application of International Human Rights Law in 
Relation to Sexual Orientation and Gender Identity.122  The Yogyakarta 
                                                                                                                 
 117. See id. (detailing the risks associated with prolonged hormone therapy). 
 118. See CHRISTOPHER A. SHELLEY, TRANSPEOPLE:  REPUDIATION, TRAUMA, HEALING 
82–91 (2008) (discussing the difficulties transsexuals face in employment and education). 
 119. See supra Part I (discussing the costs of transition-related services). 
 120. See supra Part II.B (discussing differing court decisions and jurisdictions in the 
United States).  
 121. See THE YOGYAKARTA PRINCIPLES ON THE APPLICATION OF INTERNATIONAL 
HUMAN RIGHTS LAW IN RELATION TO SEXUAL ORIENTATION AND GENDER IDENTITY 6 (Mar. 
2007), http://www.yogyakartaprinciples.org/principles_en.pdf (last visited Nov. 3, 2011) 
[hereinafter YOGYAKARTA] (discussing the current state of the international community as it 
has approached issues of gender identity and sexual orientation) (on file with the 
Washington and Lee University Journal of Civil Rights and Social Justice). 
 122. See id. at 6–7 (introducing the reasons for creating the principles, stating that “[a]ll 
human beings are born free and equal in dignity and rights” and “[a]ll human rights are 
universal, interdependent, indivisible and interrelated”). 
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Principles are a broad set of standards that recognize that all state actors 
should promote and protect human rights.123 
Principle Seventeen of the Yogyakarta Principles is particularly 
important in the healthcare context and addresses the right to the highest 
attainable standard of health.124  The signatories conclude that states should 
take all necessary measures to ensure enjoyment of the highest standard of 
health regardless of sexual orientation or gender identity.125  Subsection C 
emphasizes the need of states to “[e]nsure that healthcare facilities, goods, 
and services are designed to improve the health status of, and respond to the 
needs of, all persons . . . .”126  The recognition of the need to provide 
adequate healthcare to all is important to the current discussion because 
much of the discord among United States courts and insurance carriers 
involves disagreement about which procedures are medically necessary for 
gender variant individuals.127  Subsection G of the Yogyakarta Principles 
provides some possible clarification of this question by urging states to 
facilitate access to body modification related to gender reassignment.128 
The Yogyakarta Principles reflect international recognition of the need 
for standards in the area of transgender medical care.  The United States, as 
a participant in a larger international community, can therefore look to 
international examples as a way of developing domestic medical standards.  
It is true that inconsistent standards exist both in the United States medical 
communities and among some international medical communities, but 
examination of recently accepted international standards, in Europe and in 
certain areas of the United States, begin to reveal growing continuity.129  In 
order to understand the complex and emerging standards of care for 
transgender health, a good starting point is to examine relevant international 
organizations and the standards developed by them.  Countries and medical 
                                                                                                                 
 123. See id. at 7 (explaining the purpose and scope of the principles). 
 124. See id. at  22 (“Everyone has the right to the highest attainable standard of physical 
and mental health, without discrimination on the basis of sexual orientation or gender 
identity.”).  “Sexual and reproductive health is a fundamental aspect of this right.”  Id. 
 125. See id. (stating that states should “[t]ake all necessary legislative, administrative 
and other measures” to ensure access to healthcare without discrimination). 
 126. Id. 
 127. See supra Part II.B (discussing United States court decisions and varying 
approaches insurance carriers take). 
 128. See supra note 121, at 22 (stating that states should facilitate access to competent, 
non-discriminatory treatment, care, and support).  
 129. See discussion infra Part IV (discussing the European approach to funding 
transition-related care). 
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care providers can then implement the standards or use them as flexible 
guides for their respective medical systems.130 
B.  Addressing Specific Needs of Transgender Individuals:  The World 
Professional Association for Transgender Health 
The World Professional Association for Transgender Health 
(WPATH) is the most widely known professional organization devoted to 
the understanding and treatment of GID.131  WPATH strives to bring 
together international professionals in order to develop the best practices 
and policies to promote the health, research, education, and overall equality 
of transgender, transsexual, and gender-variant people.132   The organization 
has developed a set of standards and has released a number of statements 
and clarifications that countries around the world have adopted or 
implemented.133 
WPATH published the first version of its Standards of Care in 1979, 
with the most recent revision in February 2001.134  The Standards of Care 
                                                                                                                 
 130. See Dr. Anne Lawrence, Practice Information, http://www.annelawrence. 
com/practice/index.html (last visited Oct. 4, 2011) (providing the practice information for 
Anne A. Lawrence, located in Seattle, Washington, among which is a provision stating that 
she regards the WPATH standards as flexible guidelines) (on file with the Washington and 
Lee Journal of Civil Rights and Social Justice). 
 131. See WORLD PROF. ASS’N FOR TRANSGENDER HEALTH, http://www.wpath.org (last 
visited Oct. 18, 2011) (describing the organization) (on file with the Washington and Lee 
Journal of Civil Rights and Social Justice). 
 132. See Mission Statement, WORLD PROF. ASS’N FOR TRANSGENDER HEALTH, 
http://www.wpath.org/about_mission.cfm (last visited Oct. 18, 2011) (outlining the mission 
statement of the organization) (on file with the Washington and Lee Journal of Civil Rights 
and Social Justice). 
 133. See WORLD PROF. ASS’N FOR TRANSGENDER HEALTH, THE HARRY BENJAMIN 
INTERNATIONAL GENDER DYSPHORIA ASSOCIATION’S STANDARDS OF CARE FOR GENDER 
IDENTITY DISORDERS (6th ed. 2001) [hereinafter STANDARDS OF CARE], available at 
http://www.wpath.org/documents2/socv6.pdf (providing flexible standards of care for 
Gender Identity Disorders); see also Clarification on Medical Necessity of Treatment, Sex 
Reassignment, and Insurance Coverage in the U.S.A., WORLD PROF. ASS’N FOR 
TRANSGENDER HEALTH (2008) [hereinafter WPATH CLARIFICATION], 
http://www.wpath.org/documents/Med%20Nec%20on%202008%20Letterhead.pdf (last 
visited Nov. 3, 2011) (clarifying that sexual reassignment surgery and hormone therapy for 
transgender individuals should be classified as a medical necessity and covered under U.S. 
insurance plans) (on file with the Washington and Lee Journal of Civil Rights and Social 
Justice). 
 134. See STANDARDS OF CARE, supra note 133, at 1 (discussing the history of the 
standards of care, which originated as the Harry Benjamin International Gender Dysphoria 
Association’s Standards of Care). 
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are meant to serve as flexible instructions for the treatment of individuals 
with GID.135  By providing a set of minimum standards for 
psychotherapeutic, endocrine, and surgical therapy, WPATH hopes to 
further “lasting personal comfort with the gendered self in order to 
maximize overall psychological well-being and self-fulfillment.”136 
The Standards of Care begin by describing the history of gender 
identity disorders and by providing criteria for diagnoses.137  Individuals are 
classified as suffering from a gender identity disorder when they meet 
specified conditions in one of two official nomenclatures:  the International 
Classification of Diseases-10 (ICD-10) or the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV).138  Under the DSM-IV committee 
criteria, a person with a “strong and persistent cross-gender identification 
and a persistent discomfort with their sex or a sense of inappropriateness in 
the gender role of that sex” is diagnosed with gender identity disorder.139  
Under the ICD-10, other criteria provide more specific diagnoses.140  In 
order for an individual to be classified as “transsexual,” the individual must 
have a desire to live and be accepted as a member of the opposite sex; the 
transsexual identity must have been present for at least two years; and the 
disorder must not be the symptom of another mental disorder or 
chromosomal abnormality.141  The ICD-10 criteria also state that 
transsexuals usually undertake surgery and hormone therapy as 
treatment.142 
                                                                                                                 
 135. See id. at 1–2 (stating that the eligibility requirements are supposed to be 
minimums, which the individual professionals may modify). 
 136. See id. at 1 (explaining the overarching treatment goal of psychotherapeutic, 
endocrine, and surgical therapies). 
 137. See id. at 1–2 (outlining how professionals diagnose gender identity disorders). 
 138. See id. at 2 (describing the clinical threshold in gender identity cases). The author 
notes: 
A clinical threshold is passed when concerns, uncertainties, and questions about 
gender identity persist during a person’s development, become so intense as to 
seem to be the most important aspect of a person’s life, or prevent the 
establishment of a relatively unconflicted gender identity. 
Id. 
 139. Id. note 133, at 4 (noting that the term “transgender” has been used in various 
ways and is not a formal diagnosis, but many professionals use it because it is often easier to 
use than the formal diagnosis). 
 140.  See id. at 4–6 (detailing the criteria for transsexualism, dual-role transsexualism, 
gender identity disorder of childhood, and other gender disorders). 
 141. See id. at 4–5 (listing the three criteria for transsexualism specifically).  
 142.  See id. at 5 (“The desire to live and be accepted as a member of the opposite sex, 
usually accompanied by the wish to make his or her body as congruent as possible with the 
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Recognizing the difficulties transgender individuals face when 
pursuing surgery in the United States, WPATH released a “Clarification on 
Medical Necessity of Treatment, Sex Reassignment, and Insurance 
Coverage in the U.S.A.”143  This document calls for changes in the way the 
United States views and handles SRS and hormone therapy.144  Numerous 
large employers have already negotiated contracts with insurance carriers to 
enable medically necessary treatment for transsexualism and/or GID to be 
covered under their plans.145  More and more carriers are realizing the 
effectiveness of the treatment, and coverage is increasingly offered at no 
additional premium cost.146 
Despite this trend, there are still many instances in which transsexual 
individuals are turned away from coverage because the surgery and 
hormone therapy are not universally classified as “medically necessary.”147  
By contrast, the WPATH statement lists a number of procedures as 
medically necessary, including complete hysterectomies, genital 
reconstruction, facial hair removal, and certain facial plastic 
reconstruction.148  The WPATH Board of Directors has urged insurance 
carriers and healthcare providers in the United States not to exclude 
transgender or transsexual individuals from coverage and to provide for 
prescribed sex reassignment services.149 
IV.  The European Approach to Transition-Related Medical Care 
                                                                                                                 
preferred sex through surgery and hormone treatment.”). 
 143. See WPATH CLARIFICATION, supra note 133, at 2–3 (defining the medically 
necessary sex reassignment procedures). 
 144. See id. at 1–4 (stating that qualifying procedures as “medically necessary” is 
important in terms of access to U.S. insurance coverage and sex reassignment surgeries and 
hormone therapies should be classified as such). 
 145. See id. at 3 (stating that the City and the County of San Francisco, the University 
of California, the University of Michigan, and IBM have all negotiated contracts with their 
insurance carriers to provide coverage for medically necessary treatment in relation to 
transsexualism). 
 146. See id. (stating that Aetna, Cigna, and other carriers now have protocols 
recognizing the validity and effectiveness of treatment). 
 147. See discussion supra Part II.A (providing United States case law in which sexual 
reassignment surgery has been ruled not “medically necessary”). 
 148. See WPATH CLARIFICATION, supra note 133, at 2 (enumerating various techniques 
which may vary from patient to patient including skin flap removal and penile and testicular 
prostheses). 
 149. See id. (emphasizing the need to provide ongoing healthcare, both routine and 
specialized, that is readily accessible). 
372 18 WASH. & LEE J.C.R. & SOC. JUST. 351 (2012) 
A number of European countries adhere to the WPATH Standards and 
have increased access to critical surgeries and hormone therapies.150  Most 
European countries fund some aspects of sexual reassignment surgery, 
hormone therapy, or a combination of both.151  Thirteen of the twenty-seven 
European Union member states provide funding for psychotherapy, which 
extends beyond a mental health evaluation of the patient and continues to 
ensure the patient’s mental health throughout the transition period and 
afterward.152  Some countries offer psychotherapy only occasionally 
because of its high costs.153  Hormone replacement therapy, both before and 
after surgery, is provided by at least seventeen countries.154 
Many of the countries fund surgical procedures to alter primary and 
secondary sex characteristics.155  Primary sex characteristics include 
vaginoplasty and phalloplasty.156  Approximately half of the EU countries 
fund each of these surgeries.157  For procedures such as phalloplasty, the 
quality of the surgery is important in assessing the country’s willingness to 
provide funding.158  If the phalloplasty is accomplished through minimal 
procedures, a state could be more likely to classify it as cosmetic.159  
Conversely, a more extensive surgery might have a better chance at 
obtaining funding.160  Funding of primary sex characteristics may therefore 
                                                                                                                 
 150. See STEPHEN WHITTLE ET AL., TRANSGENDER EUROSTUDY:  LEGAL STUDY AND 
FOCUS ON THE TRANSGENDER EXPERIENCE OF HEALTH CARE 25 (2008), available at 
http://www.ilga-europe.org/home/issues/trans/ie_resources/transgender_eurostudy_legal_ 
survey_and_focus_on_the_transgender_experience_of_health_care_april_2008 (stating that 
many European countries follow the WPATH standards in providing for psychotherapy). 
 151. See id. (providing general statistics regarding the funding of surgeries and 
hormone therapy provided by governments of various European countries).  
 152. See id. (explaining the comprehensive psychotherapy funded by various European 
countries for transitioning patients). 
 153. See id. (stating that the notable exception to providing psychotherapy is the United 
Kingdom because of the high cost of the treatment and the fiscal limitations of the National 
Health Service). 
 154.  Id. 
 155. See id. (citing that up to thirteen countries provide genital reconstruction surgeries 
for both men and women). 
 156. Id. 
 157.  See id. (stating that thirteen countries fund vaginoplasty for transsexual women, 
with a similar figure providing phalloplasty for men). 
 158. See id. at 25–26 (addressing the impossibility of accessing the quality of 
treatments provided). 
 159. See id. (citing vaginoplastics in the Czech Republic as an example of a minimal, 
purely cosmetic procedure, that is not funded). 
 160. See id. (stating that the Czech Republic provides for phalloplasty, which is four to 
five times the cost of vaginoplasty, but does not fund vaginoplasties).  This may be because 
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depend on the surgical method. The secondary sex characteristics include 
breast augmentation, bilateral mastectomies, and hysterectomies.161  Over 
half of the European Union countries fund bilateral mastectomies and 
hysterectomies.162 
A.  The Changing Legal Landscape 
The increase in public funding for sex reassignment procedures is 
attributable in part to the changing legal views towards transsexuals in 
European courts and law-making bodies.163  Although there were general 
successes in combating discrimination against transgender individuals prior 
to 2002,164 a wider movement for change began with the European Court of 
Human Rights (ECHR) case of Goodwin v. United Kingdom.165  Goodwin 
was a post-operative male to female transsexual who alleged that her 
employer had dismissed her from work because of her transsexuality.166  
The court found that there were violations of Articles 8, 12, and 14 of the 
Convention for the Protection of Human Rights and Fundamental Freedoms 
(the Convention).167  The ECHR decision upheld protections for 
                                                                                                                 
the Czech Republic does not offer the most extensive surgery possible.  Id. 
 161. See id. (stating that six countries fund breast augmentation surgery for transsexual 
women). 
 162.  See id. (stating that sixteen countries publicly fund bilateral mastectomies and 
fifteen countries fund hysterectomies). 
 163. See id. at 17–21 (providing an overview of European Union anti-discrimination 
legislation including decisions by the European Court of Human Rights and the European 
Court of Justice on transgender rights). 
 164. See id. at 17 (discussing the emergence of protection against discrimination to 
transgender people in employment and protection in goods and services). 
 165. See id. at 18 (stating that Goodwin v. United Kingdom began a broader movement 
for transgender legal rights); see also Goodwin v. United Kingdom, App. No 28957/95, Eur. 
Ct. H.R. (2002), http://archive.equal-jus.eu/74/1/Christine_Goodwin_v._The_United_ 
Kingdom_(GC)%2C_no._28957:95.pdf (last visited Oct. 18, 2011) (recognizing the right to 
private life and the right to marry for transgendered individuals, and acknowledging that the 
United Kingdom national health service and a majority of contracting states, recognize the 
condition of gender identity disorder and provide or permit surgery) (on file with the 
Washington and Lee Journal of Civil Rights and Social Justice). 
 166. See Goodwin, App. No. 28957/95, § 15 (stating that although her dismissal was 
supposedly connected with her health, applicant argued that it was actually because of her 
transsexuality).  Applicant also argued that she suffered past discrimination at jobs because 
of her transsexuality.  Id.  In addition, she feared that employers would discriminate against 
her without issuance of a new National Insurance number.  Id. § 16. 
 167. See id. § 59 (explaining that Article 8 of the Convention states that “[e]veryone 
has the right to respect for his private . . . life”).  The court found through a balancing test 
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transsexuals for the right to marry, to found a family, and to have their 
private lives protected.168 
The court in Goodwin also addressed the notion of transsexualism as a 
“choice.”169  It stated that most European states acknowledge the existence 
of the condition of transsexualism, with the vast majority providing, or at 
least permitting, treatment, including irreversible surgeries.170  The court 
additionally reasoned that the level of commitment necessary to undergo 
gender reassignment surgeries is proof that the decision to undertake 
surgery is not an “arbitrary and capricious” decision.171  Because of the 
widespread acceptance of transsexualism as a medical diagnosis, the 
ongoing debate as to the specific cause is decreasing in relevance since the 
most important factor is that transsexuals do not choose the condition.172 
The European Court of Human Rights’ acknowledgement of the 
importance of gender reassignment surgery paved the way for additional 
cases expanding the rights of transsexuals. 173 One such case was L v. 
Lithuania174; L was a transitioning female to male.175  He underwent partial 
                                                                                                                 
that there were no significant factors of public interest to weigh against the interest of 
providing Christine Goodwin with legal recognition of her gender reassignment.  Id. § 93;  
see also id. § 94 (stating that Article 12 of the Convention provides for the right to marry).  
The court concluded that a violation of Article 12 had occurred because of the government’s 
denial of applicant’s new insurance number.  Id. § 104;  see also id. § 105 (stating that 
Article 14 of the Convention provides for the rights set forth in the Convention to be secured 
without discrimination).  The court found that this issue had been examined under Article 8 
of the Convention.  Id. § 108. 
 168. See id. § 103 (stating that the court found no justification for barring transsexuals 
the right to marry). 
 169. See id. § 81 (stating that there are no conclusive findings as to the cause of 
transsexualism and whether it is psychological or associated with physical differentiation in 
the brain). 
 170. See id. (finding that transsexualism has wide international recognition as a medical 
condition with a prescribed treatment). 
 171. See id. (stating that the numerous painful procedures necessary for gender 
reassignment make it unlikely that people undertake the surgery arbitrarily and capriciously). 
 172. See id. (finding that the ongoing medical and scientific debate as to the exact 
causes of transsexualism is of diminishing importance). 
 173. See L. v. Lithuania, App. No. 27527/03, Eur. Ct. H.R., §§ 59–60 (2008), http://cmi 
skp.echr.coe.int/tkp197/view.asp?action=html&documentId=823071&portal=hbkm&source
=externalbydocnumber&table=F69A27FD8FB86142BF01C1166DEA398649 (last visited 
Oct. 18, 2011) (finding that Lithuania violated the Convention for the Protection of Human 
Rights and Fundamental Freedoms by not allowing procedures for gender reassignment 
surgery) (on file with the Washington and Lee Journal of Civil Rights and Social Justice). 
 174. See id.  (finding a violation of the Convention for the Protection of Human Rights 
and Fundamental Freedoms by the Lithuanian government). 
 175. See id. § 7 (stating that the applicant knew from an early age that he was aware his 
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gender reassignment surgery by having his breasts removed and agreed 
with his doctors that further surgeries were appropriate.176  In order to 
receive the further treatment he needed in Lithuania, L was waiting on the 
passage of a Gender-Reassignment Bill.177  The government delayed 
passing the bill, which meant that the surgery could not be conducted in 
Lithuania.178  Without the additional surgery, L remained female under 
domestic law.179  The court found that the government had waited too long 
to implement the laws that would allow for the completion of gender 
reassignment surgery.180  By not allowing this type of surgery in the 
country, the Lithuanian government violated Article 8 of the Convention 
for the Protection of Human Rights and Fundamental Freedoms.181  With a 
majority of European Union states offering gender reassignment surgery, L 
v. Lithuania gave strong support to transsexuals seeking all aspects of the 
transition process. 
There have also been significant gains relating directly to insurance 
coverage for transition-related care.  An issue paper by Thomas 
Hammerberg, the Council of Europe Commissioner for Human Rights, 
examines the current ability of transgender individuals to access transition-
related services, if they choose to transition.182  The case law of the ECHR 
requires states to at least provide for the possibility of surgeries that will 
eventually lead to full gender reassignment, as was the case in L v. 
Lithuania.183  Additionally, the Commissioner notes that case law also 
                                                                                                                 
mental state was male). 
 176. See id. § 19 (stating that L underwent breast removal from May 3 to May 9, 2000). 
 177. See id. §§ 25–30 (describing the Civil Code adopted in 2001, which provided that 
an unmarried adult had the right to gender reassignment surgery, and noting that the Gender 
Reassignment Bill, which was to be added to the Civil Code, was omitted from the 
Parliament’s agenda). 
 178. See id. § 30 (stating that the government dropped the Gender Reassignment Bill 
from the Parliament’s agenda). 
 179. See id. § 39 (detailing L’s argument that the removal of the Gender Reassignment 
Bill left him without the ability to finish his transition). 
 180. See id. § 59 (finding that budgetary constraints do not justify four years of inaction 
on legislation). 
 181. See id. § 60 (concluding the government violated Article 8). 
 182. See Thomas Hammerberg, Human Rights and Gender Identity, OFFICE OF COMM’R 
FOR HUMAN RIGHTS, 7–8 (July 29, 2009), https://wcd.coe.int/com.instranet.InstraServlet? 
Index=no&command=com.instranet.CmdBlobGet&InstranetImage=1824655&SecMode=1
&DocId=1433126&Usage=2 (stating that the paper addressed the human rights concerns 
regarding transgender person). 
 183. See id. at 26 (“The European Court of Human Rights has established as a positive 
duty that states provide for the possibility of undergoing surgery leading to full gender-
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states that insurance plans in the European Union should cover “medically 
necessary” treatment in general, which includes gender reassignment 
surgery.184  The Commissioner goes further to say that all Council of 
Europe member states should apply that standard to insurance plans in their 
respective countries.185 
B.  Coverage of Transition-Related Procedures in Specific Countries 
While standards for the transition-related care have clearly begun to 
emerge in Europe, there are still inadequacies in many European Union 
countries.  Ultimately 80% of transgender people in the EU were refused 
state funding for hormone treatment, and 86% of transgender people are 
refused state funding for surgical procedures.186  Because of the persistent 
difficulty in obtaining state funds, 50% of transgender individuals in the EU 
must individually pay for their procedures.187  These statistics are surprising 
given the recent successes for the European transgender community.188  
One of the biggest reasons for the high rate of refusal for funding is the 
European Union’s lack of enforcement.189  It is therefore necessary to 
examine some important European countries in detail, in order to see which 
surgeries they most often fund, the processes for state funding, and why 
countries might be failing at the implementation phase. 
1.  The United Kingdom 
                                                                                                                 
reassignment.”). 
 184. See id. (stating that European Court of Human Rights case law calls for coverage 
under insurance plans). 
 185. See id. (stating that the standards should be adopted by all Council of Europe 
states). 
 186. See WHITTLE, supra note 150, at 54 (finding that more respondents who 
transitioned less than five years ago had been refused funding for hormones than those who 
transitioned more than ten years ago). 
 187. See id. at 56–57 (providing the percentage of respondents who were refused 
treatment and paid themselves). 
 188. See id. at 54 (“This is a worrying finding as the assumption would be that access to 
funding for treatment would be improving.”). 
 189. See id. at 68 (“One of the most frustrating aspects of the EU for trans people has 
been its failure to ensure that Member States are meeting their obligations under the 
directives, regulations, policies and case law.”). 
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The United Kingdom has established one of the most universal 
healthcare systems in the world.  All people “ordinarily resident” in the 
United Kingdom are entitled to health care.190  The National Health 
Services (NHS) of England, Scotland, Wales, and Northern Ireland 
accounts for 86% of total health expenditure and is funded through general 
taxation.191  In England, the Department of Health holds the management 
responsibility, while decisions about service delivery and local priority lie 
with the Strategic Health Authorities and the Primary Care Trusts.192 
In the United Kingdom, the treatment referral pathway for gender 
reassignment surgery is often similar to the one utilized in the United States 
and generally follows the WPATH standards.193  The Worcestershire 
Commissioning Policy and Referral Guidelines for Gender Dysphoria 
Services gives an example of this pathway.194  A physician must first 
diagnose the patient with Gender Identity Disorder.195  Leading up to the 
commencement of hormone therapy, the patient must perform the real life 
test (RLT), which includes a minimum of two years living as the opposite 
gender to that assigned at birth.196  After three months of the RLT, the 
patient begins the initial phases of hormone therapy.197  Surgery is allowed 
only if the patient meets strict qualifications, including performing the RLT, 
obtaining ongoing hormone therapy, and changing his or her name 
legally.198  There are problematic qualifications in parts of the United 
                                                                                                                 
 190. See Sean Boyle, The UK Health Care System, THE COMMONWEALTH FUND (2008), 
http://www.commonwealthfund.org/usr_doc/UK_Country_Profile_2008.pdf?section=4061 
(last visited Oct. 18, 2011) (“Coverage is universal.”) (on file with the Washington and Lee 
Journal of Civil Rights and Social Justice). 
 191. See id. (stating that the NHS is mainly funded by general taxation, as well as by 
national insurance contributions and user charges). 
 192. See WHITTLE, supra note 150, at 33 (discussing the National Health System in the 
United Kingdom). 
 193. See supra Part III.B (discussing the WPATH Standards of Care). 
 194. See WORCESTERSHIRE PRIMARY CARE TRUST, COMMISSIONING POLICY AND 
REFERRAL GUIDELINES FOR GENDER DYSPHORIA SERVICES AND GENDER REASSIGNMENT 
SURGERY IN ADULTS 2 (July 2008), available at http://www.worcestershire. 
nhs.uk/search.aspx?q=%22GENDER+DYSPHORIA+SERVICES%22&type=docs 
[hereinafter COMMISSIONING POLICY] (stating that the guidelines describe the criteria for 
referral to gender identity services and for gender reassignment surgery). 
 195. See id. at 4 (stating that patients must have an initial diagnosis of transsexualism or 
GID by a local consultant psychiatrist). 
 196. See id. at 5 (stating that periods of returning to their original gender should be 
excluded from the two year RLT). 
 197. See id. (including the criteria that patients demonstrate knowledge of what 
hormones can and cannot do medically). 
 198. See id. (requiring that the patient change his or her name to one “appropriate to the 
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Kingdom.  One such qualification is the requirement that the patient 
maintain employment or education in the desired gender role for a 
minimum of one year.199  This is often difficult due to discrimination in 
areas of employment and education.200  Additionally, patients may be 
forced to wait up to three years for surgery due to the current demand for 
the procedures.201 
Despite some shortcomings in the specific referral process, the 
United Kingdom provides funding for most aspects of transition-related 
care under the NHS.202  Among the funded procedures are hormone 
replacement therapy, bilateral mastectomies, hysterectomies, 
vaginoplasties, and phalloplasties.203  Assuming that full gender 
reassignment constitutes surgery to augment the genitals and hormone 
replacement therapy, funding for these procedures is a success for 
transgender individuals living in the United Kingdom because it 
provides for the minimum number of procedures to achieve full gender 
reassignment.204  Some individuals may feel that other procedures are 
crucial to his or her complete transition. Psychotherapy, often seen as a 
crucial part of the gender reassignment process, is not available from the 
NHS because of the therapy’s high cost and the fiscal limits of the 
NHS.205  In addition, procedures such as permanent hair removal and 
breast augmentation surgeries are not considered crucial aspects to the 
gender reassignment process and are not covered by the NHS.206  There 
are therefore notable shortcomings since numerous procedures are not 
covered under the national health plan.  Transsexual individuals desiring 
to undergo those procedures may find aid, however, from the strong 
                                                                                                                 
transgendered self”). 
 199. See id. (“Patients should have found employment, or been in education or training, 
in their desired gender role for a minimum period of one year, including employment in the 
voluntary sector.”). 
 200. See discussion supra note 166 (discussing Goodwin v. United Kingdom and the 
difficulties Christine Goodwin faced in terms of employment). 
 201. See HEATH, supra note 30, at 93 (stating that many clients seek private surgical 
arrangements because the National Health Service waiting time is three years). 
 202. See WHITTLE, supra note 150, at 25 (detailing the procedures publically funded by 
the United Kingdom). 
 203. Id. 
 204. Id. 
 205. See id. (stating that the fiscal limitations of the NHS prevent some funding for 
psychotherapy). 
 206. See COMMISSIONING POLICY, supra note 194, at 6 (stating that “breast presence or 
size is not a defining characteristic of sex or gender”). 
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suggestion that insurance plans should cover all “medically necessary” 
procedures.207  While breast augmentation and hair removal are still 
largely seen as cosmetic, psychotherapy may have a better chance at 
being classified as “medically necessary” because it is one of the 
prerequisites for surgery. 
Other shortcomings exist for transsexual individuals after surgery.  
For many years, the government refused to change identification 
documents to match the new sex.208  In 2002, the ECHR issued a 
statement to the British government telling it to recognize new gender 
statuses on government documents.209  While there have been some 
successes in the United Kingdom with legislation such as the Gender 
Recognition Act of 2004, there are still areas of protection that need 
improvement.210  One example of necessary improvements is in the area 
of pension rights.  The Council of Europe Commissioner for Human 
Rights has found that transgender women have been denied the same 
pension rights received by other women in the United Kingdom.211  Even 
with the need for improvements in areas after surgery, the United 
Kingdom is still a prime example of how European countries are 
expanding rights for transgender individuals and recognizing most 
aspects of gender reassignment surgery as “medically necessary.” 
2.  Germany and Sweden 
Unlike the United Kingdom, Germany and Sweden provide funding 
for every aspect of the gender reassignment process.212  In Germany, care is 
                                                                                                                 
 207. See discussion supra note 182 and accompanying text (discussing Thomas 
Hammerberg’s call for all European Union members to cover SRS under insurance plans). 
 208. See GREEN, supra note 1, at 92 (stating that prior to 2002 transsexuals faced 
difficulties in obtaining employment, pensions, and marriage licenses). 
 209. See id. (stating that the order resulted from a thirty-year battle involving numerous 
petitions from British citizens). 
 210. See Gender Recognition Act, 2004, c. 7, § 9 (U.K.) (stating that when a full gender 
recognition certificate is issued, the person’s gender becomes the acquired gender). 
 211.  See Discrimination Against Transgender Persons Must No Longer be Tolerated, 
STOP TRANSPHOBIA (Jan. 11, 2009) http://stoptransphobia.wordpress.com/2009/01/11/%E2 
%80%9Cdiscrimination-against-transgender-persons-must-no-longer-be-tolerated% 
E2%80%9D/ (last visited Nov. 3, 2011) (providing an excerpt from the Commissioner for 
Human Rights detailing the failures of the United Kingdom government) (on file with the 
Washington and Lee Journal of Civil Rights and Social Justice). 
 212. See WHITTLE, supra note 150, at 22 (detailing the procedures publically funded by 
Germany and Sweden). 
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financed by a combination of statutory health insurance, general taxation, 
private health insurance, and some user co-payments.213  Compulsory 
contributions, split between employers and employees, are put into one of a 
large number of sickness funds.214  The type of sickness fund determines 
how much a person must contribute and the type of healthcare services 
available.215  Sweden has a similar universal healthcare structure.  Services 
are covered based on three main principles:  equal access, care based on 
need, and cost effectiveness.216  Approximately 70% of healthcare services 
in Sweden are funded through local government taxes.217  In 2007, only 3% 
of the Swedish population was covered by private insurance.218 
German and Swedish transsexuals have the possibility to obtain state-
sponsored funding of all transition-related treatments.219  Providing public 
funding for hair removal is a unique and important success.220  Hair 
removal is similar in cost to full genital surgery and is often considered 
essential in order to live successfully as a woman.221  In addition to hair 
removal procedures, Germany provides breast augmentation surgery for 
transsexual women.222  Both Germany and Sweden provide funding for 
psychotherapy, vaginoplasty, mastectomy, phalloplasty, and 
metoidioplasty.223 
                                                                                                                 
 213. See REINHARD BUSSE, THE COMMONWEALTH FUND, THE GERMAN HEALTH CARE 
SYSTEM 2–3, http://www.allhealth.org/briefingmaterials/CountryProfiles-FINAL-1163.pdf 
(last visited Nov. 3, 2011) (stating that the publicly funded scheme is operated by over 200 
competing health insurance funds) (on file with the Washington and Lee Journal of Civil 
Rights and Social Justice). 
 214. See WHITTLE, supra note 150, at 31–32 (“Currently, the healthcare system is 
funded by compulsory contributions that are split between employers and employees and are 
put into one of a large number of sickness funds.”). 
 215. See id. (stating that the 252 sickness funds insure approximately 90% of the 
population). 
 216. See Sweden’s HealthCare System, SWEDISH HEALTHCARE ACADEMY, 
http://www.swedishhealthcare.se/sida1.html (last visited Nov. 3, 2011) (stating that those 
included are not actually enumerated) (on file with the Washington and Lee Journal of Civil 
Rights and Social Justice). 
 217. See id. (stating that most of the public financing comes from county council taxes). 
 218. See id. (suggesting that private insurance is on the rise). 
 219. See WHITTLE, supra note 150, at 22 (providing a chart of all the procedures 
Germany and Sweden publicly fund). 
 220. See id. at 25 (stating that only Germany and Sweden publicly fund hair removal). 
 221. See id. (stating that the cost of hair removal greatly exceeds the cost of breast 
augmentation and that it is similar to the cost of full genital surgery). 
 222. See id. (including Germany as one of six countries that proved public funds for 
breast augmentation). 
 223. Id. 
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While both countries allow for the possibility of government funding 
for all procedures, the systems have some limitations and drawbacks.  For 
example, both countries fund the surgeries, but still require sterilization in 
order to have birth records changed after surgery.224  In the United 
Kingdom, a person can easily change his or her name, but Germany and 
Sweden require all aspects of surgery and hormone treatment in addition to 
permanent sterility in order for a name change to be granted.225  There is, 
however, a trend towards greater protection for transitioned individuals.  
Swedish Prime Minister Fredrik Reinfeldt and the National Board of Health 
and Welfare are making efforts to remove the law in Sweden that requires 
permanent sterility.226  The transsexual community in Germany is hopeful 
that the new government will reform the “Transsexual Law” and deal with 
some of these issues within the next legislative period.227 
Finally, both systems are constrained by monetary issues.  Sweden’s 
system is based on need and cost effectiveness.228  Even if all of the 
procedures are determined to be necessary to an individual patient, cost 
effectiveness could play a role and eliminate more traditionally “cosmetic” 
surgeries, such as breast augmentation and hair removal.229  The same is 
true for Germany, where long-term affordability of healthcare reform 
remains a strong concern.230  If costs are too high, it may mean that national 
                                                                                                                 
 224. See WHITTLE, supra note 150, at 26 (stating that France, Germany, Lithuania, and 
Sweden can sometimes require permanent sterility). 
 225. See id. (stating that the United Kingdom has no legal obstruction to changing a 
person’s name to something that is more appropriate to their new gender, while Germany 
and Sweden require medical intervention up to and including treatment to render permanent 
sterility). 
 226. See Sex Change Sterilization “A Dark Chapter”:  Reinfeldt, THE LOCAL (Jul. 13, 
2010), http://www.thelocal.se/28114/20100731/ (last visited Nov. 3, 2011) (stating that 
leaders of Sweden’s seven political parties have expressed support to amend legislation that 
forces compulsory sterilization in order to get a divorce after a sex change) (on file with the 
Washington and Lee Journal of Civil Rights and Social Justice). 
 227. See C. Balzer & A. Suess, TvT Research Project Country Results:  Germany—
Elaborated Version, TRANS RESPECT VERSUS TRANSPHOBIA WORLDWIDE (Jan. 2010) 
http://www.transrespect-transphobia.org/en_US/countries/germany-1/germany-2.htm (last 
visited Nov. 3, 2011) (providing a list of initiatives regarding the recognition of transgender 
rights in the national constitution) (on file with the Washington and Lee Journal of Civil 
Rights and Social Justice).  
 228. See discussion supra at note 216 and accompanying text (describing Sweden’s 
healthcare system). 
 229. See id. (describing Sweden’s healthcare system). 
 230. See WHITTLE, supra note 150, at 32 (stating that long-term affordability remains 
an important concern for Germany’s healthcare system). 
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health insurances will not cover breast augmentation or hair removal.231  
What is important, however, is that transgender individuals in Germany and 
Sweden have some options for funding under a national insurance plan, a 
private insurance plan, or a combination of the two.  These choices are in 
stark contrast to the situation in the United States, where insurance 
providers can exclude coverage as they see fit.232 
3.  Italy and Spain 
Several European countries, such as Italy and Spain, are severely 
lacking in provisions for transgender needs, but even these countries have 
shown some positive trends.  Italy provides for gender reassignment 
surgery free of charge in hospitals, but the procedures are subject to the 
authorization of courts.233  Surgical procedures to alter both primary and 
secondary sex characteristics are funded by the Italian government.234  Italy 
applies its own set of standards for determining eligibility and providing 
reassignment procedures.235  The Italian standards state that SRS can be 
carried out after obtaining a court order.236  In order to get a court order, 
individuals must meet certain qualifications, including the criteria for 
reassignment established in DSM-IV and ICD-10.237  Hormone replacement 
                                                                                                                 
 231. See Balzer & Suess, supra note 227 (stating that health insurance in Germany does 
not often cover hair removal or breast augmentation). 
 232. See supra Part II.B (discussing how insurance companies can exclude coverage for 
various medical procedures). 
 233. See Submission to the United Nations Human Rights Council for its Universal 
Periodic Review of Italy, Italy:  The Status of Lesbian, Gay, Bisexual and Transgender 
Rights 5 (Seventh Session) http://lib.ohchr.org/HRBodies/UPR/Documents/Session7/IT/J1 
_UPR_ITA_S07_2010_JointSubmission1.pdf (last visited Nov. 3, 2011) (stating that gender 
reassignment surgery is subject to the authorization of courts) (on file with the Washington 
and Lee Journal of Civil Rights and Social Justice). 
 234. See WHITTLE, supra note 150, at 22 (providing a chart of the procedures Italy 
publicly funds, including vaginoplasties, hysterectomies, and phalloplasties). 
 235. See Anna R. Ravenna, Italian Standards of Care for Sex Reassignment in Gender 
Identity Disorder, 2 INT’L J. OF TRANSGENDERISM 4 (1998), available at 
http://www.iiav.nl/ezines/web/IJT/97-03/numbers/symposion/ijtc0602.htm#STANDARDS 
%20OF%20CARE%20FOR%20SEX%20REASSIGNMENT%20IN%20GENDER%20IDE
NTITY%20DISORDER%20(DSM%20IV%20302.85) (stating that the standards are to be 
minimal requirement recommendations only). 
 236. See id. at Procedure Criteria B5 (stating that a court order and a common 
agreement of the operators must be obtained in order to undergo surgery). 
 237. See id. (explaining the requirements for obtaining a court order). 
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therapy is also not provided by the Italian government even though it is 
required before a court will allow surgery.238 
Spain is another example of a European country that does not offer 
much protection for its transgender community, especially funding for 
gender reassignment surgery.239  At the time of the Transgender Eurostudy, 
Spain provided public funding only for hormone therapy and 
psychotherapy.240  Occasionally the government has provided funding for 
vaginoplasties, but it does not provide funding for primary and secondary 
surgical procedures, hair removal, or breast augmentation.241 
There have been recent movements in Spain to include gender 
reassignment procedures in the public health services.242  The political 
parties Bloque Nacionalista Gallego and Esquerra Republicana Catalunya 
have supported proposals that would include the gender reassignment 
process in the national Public Health System.243  There are several 
autonomous communities within Spain that have included gender 
reassignment procedures as covered services, including Aragon, Asturias, 
Basque Country, Canaries, Catalonia, Community of Madrid, Community 
of Valencia, and Extremadura.244  While there are no standard protocols for 
all of these communities, the process largely adheres to the WPATH 
Standards of Care.245  If a surgery is not offered in an area, patients are 
referred to units that provide them.246  In some cases, if a person is referred 
                                                                                                                 
 238. See WHITTLE, supra note 150, at 22 (stating that Italy does not provide public 
funding for hormone therapy). 
 239. See id. (indicating that Spain provides public funds for psychotherapy and 
hormone therapy). 
 240. Id. 
 241. See id. (stating that Spain has occasionally provided funding for vaginoplasties). 
 242. Id. 
 243. See TVT Research Project Country Results:  Spain—Elaborated Version, TRANS 
RESPECT VERSUS TRANSPHOBIA WORLDWIDE, (May 2010) http://www.transrespect-
transphobia.org/en_US/countries/spain-1/spain-2.htm (last visited Nov. 3, 2011) (stating that 
the political parties have pressed for coverage of gender reassignment process on the 
national level) (on file with the Washington and Lee Journal of Civil Rights and Social 
Justice). 
 244. See id. (providing a list of autonomous communities that have opted to cover the 
gender reassignment process). 
 245. See id. (stating that “Gender Identity Disorders Units” are set up according to the 
WPATH Standards of Care). 
 246. See id. (explaining that patients are referred to units if the unit they are currently in 
does not perform the needed surgery). 
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to a different area, the public health system will pay for the referral costs, 
but that payment is not a guarantee.247 
Italy and Spain are therefore two examples of European countries that 
provide the least in terms of funding for gender reassignment procedures.248  
Despite those failures, both countries show evidence of change towards 
greater protection for transgender individuals.  Italy provides funding for 
surgeries subject to court approval.249  Transgender individuals have access 
to surgeries, but improvements in financing hormone therapy and long-term 
care are necessary.  Spain, on the other hand, offers little national funding 
for gender reassignment, but specific communities have begun to cover 
transition-related procedures.250  The evidence of political parties 
attempting to include gender reassignment procedures under the national 
health scheme provides another example of the changing attitude similar to 
other European countries. 
4.  Summary of the Country-by-Country Analysis 
While current statistics show that many transitioning individuals in 
Europe are denied funding for their treatments, there are a few explanations 
and important lessons from the experiences in the United Kingdom, 
Germany, Sweden, Italy, and Spain.251  First, monetary constraints are an 
important factor in providing adequate care.252  Transsexuals in the United 
Kingdom face long waiting lists because of a lack of resources, while those 
in Germany and Sweden are denied funding for certain procedures in order 
to save costs.253  Second, there is a problem with enforcement of health 
standards, especially from the European Union.254  There is an immense 
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difficulty in preventing all types of discrimination, including by individual 
insurance agencies and medical facilities. 
The country-by-country analysis demonstrates that a majority of 
European countries are recognizing the need for some form of coverage of 
Gender Reassignment Surgery.  Even in Italy and Spain, countries that fund 
very few procedures, there are large movements pushing for reform.255  
Additionally, examination of the European countries provides a strong 
argument in favor of classifying all of the procedures associated with 
gender reassignment as “medically necessary.”256  The lessons of the 
European community should be used as a framework for providing 
transsexuals in the United States with adequate care. 
V.  Conclusion:  Applying Lessons from the International Community to the 
United States 
There is already significant evidence that the American medical 
community is amenable to the standards established by the WPATH and in 
Europe.257  First, the American Medical Association (AMA) passed a 
resolution on June 16, 2008, supporting public and private health insurance 
coverage for treatment of gender identity disorder.258  The resolution states 
that an established body of medical research demonstrates the effectiveness 
and medical necessity of mental health care, hormone therapy, and SRS.259  
Further, the categorical exclusion of surgical treatments for GID in health 
insurance plans represents discrimination based solely on the patient’s 
gender identity.260 
A second example that the United States is amenable to these 
standards came with the 2010 decision by the United States Tax Court in 
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O’Donnabhain v. Commissioner of Internal Revenue.261  The court ruled 
that sex reassignment surgeries qualify as deductible medical expenses 
under IRS Code § 213.262  This court ruling indicates that hormone therapy 
and transition-related surgeries are not considered “cosmetic.”263  The 
opinion further recognizes that breast augmentation is not cosmetic in 
certain circumstances.264 
Viewing the recent Tax Court decision, the AMA resolution, the 
differing standards among the states, and the statements by WPATH urging 
the United States to reform in conjunction, it is clear that uniform change 
needs to occur in the United States.  While there are still a significant 
number of European transgender individuals who must pay for their own 
procedures, the recognition that gender reassignment procedures are 
medically necessary is apparent.  Some argue that classification of GID as a 
mental disorder creates further issues,265 but under current international 
standards, diagnosis with GID is crucial to obtaining care.266  Once 
diagnosed with GID, Americans should have adequate access to the 
necessary treatments. 
In order for the United States to meet the standards of care most 
European countries ascribe to, there can be no categorical exclusion of 
gender reassignment procedures under insurance plans.  Resolving the 
exclusion problem under state Medicaid statutes ultimately depends on 
whether the procedures pursued by transgendered individuals qualify as 
“medically necessary.”  The international community studied in this 
discussion presents an increasingly clear consensus that transition-related 
procedures are in fact medically necessary for those individuals diagnosed 
with GID.267  The predominant standards of care are those developed by 
WPATH which explicitly states that all transition-related processes are 
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necessary for a transsexual to live a complete and full life.268  Although 
some European countries do not provide funding for all aspects of 
transition-related care, most acknowledge that the procedures are medically 
necessary.269  In countries not already acknowledging the necessities of 
these procedures, such as Italy and Spain, movements have begun to take 
shape encouraging them to follow the WPATH standards.270 
Application of these international lessons can occur at either the 
federal or the state level.  Including the WPATH standards in federal 
legislation would be ideal to provide uniform coverage.  This could be done 
through the national Medicaid statute or in a national health care bill such 
as the Patient Protection and Affordable Care Act.  Through this method, 
the WPATH Standards of Care could be enumerated and the specific 
procedures could be classified as “medically necessary.”  Advocates for the 
transgender community such as Pooja Gehi and Gabriel Arkles have 
pointed out the difficulties of such a solution.271  The topic is one of intense 
debate and disagreement.  Additionally, the current economic conditions in 
the United States, the national debate over health care, and the unresolved 
nature of the medical necessity of transition-related procedures in the 
United States all produce difficulties for creating national legislation on the 
issue.  Instead, Gehi and Arkles have suggested that the focus of change 
should be on the state level first.272 
States should explicitly declare that transition-related procedures are 
medically necessary for Medicaid purposes and adopt the WPATH 
standards.  The main challenge is the disagreement among the medical 
community in the United States.273  One way to encourage states to adopt 
uniform legislation is through a body such as the Uniform Law 
Commission.274   The commission could take the information learned from 
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the international community and use it to create legislation that is uniform 
across states.  While individual states will have to be convinced to adopt the 
legislation, the Uniform Law Commission is a convenient way to present 
the current information to them.  States need uniformity under their 
Medicaid statutes in order to prevent court decisions such as Casillas and 
Smith.275  Standardization would also help to provide more support to 
transsexual individuals through private health insurance.  Because private 
insurance operates under contract law, the individual purchasing the 
insurance must ensure that there is adequate coverage for his or her needs.  
When the contract is ambiguous, as in Davidson, having uniform medical 
standards would provide aid to transgender individuals arguing that 
transition-related procedures are not cosmetic.276 
The situation is dire and calls for action.  The lack of uniform medical 
standards for transition-related services leaves many transsexuals without 
necessary procedures and causes some to turn to such extremes as 
prostitution or traveling to countries with less restrictive medical 
standards.277 European countries are already seeing this trend and 
recognizing the need to provide for the medical procedures.  The United 
States should follow the international example.  While it may be difficult to 
promote federal legislation at the moment, states should adopt the 
international standards and apply them to state Medicaid programs.  
Hopefully, once the medical community in the United States has recognized 
the necessity of these procedures, the national government will be able to 
follow suit and provide even further protection.  These measures will help 
to fulfill the fact that transsexualism is not about surgery, but about life. 
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